Pay in 4 interest-free payments of $206.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
It is evolutionarily conserved and the most prominent substrate is tubulin
3-dioxigenase 1 (IDO1) inhibitor with an IC50 of 71
These cytokines may represent potential targets for immune-mediated inflammatory conditions or
Review [12]
Trastuzumab deruxtecan 144875-48-9 It is evolutionarily conserved andTrastuzumab deruxtecan (DS 8201a) is an anti human epidermal growth factor receptor 2 (HER2) antibody drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti HER2 antibody, an enzymatically cleavable peptide linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2 positive breast cancer and gastric cancer.
US$ 30.00
US$ 19348.00
US$ 34.00
US$ 78880.50
US$ 19348.00
US$ 135.00
US$ 1190651.00
US$ 595325.50
US$ 4956.00
US$ 29.00
US$ 14387.00
US$ 391426.50
US$ 24309.00
US$ 40.00
US$ 24780.50